Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 37

1.

Maternal resveratrol administration protects against gestational diabetes-induced glucose intolerance and islet dysfunction in the rat offspring.

Brawerman GM, Kereliuk SM, Brar N, Cole LK, Seshadri N, Pereira TJ, Xiang B, Hunt KL, Fonseca MA, Hatch GM, Doucette CA, Dolinsky VW.

J Physiol. 2019 Aug;597(16):4175-4192. doi: 10.1113/JP278082. Epub 2019 Jul 21.

PMID:
31240717
2.

Emergency management of adrenal insufficiency in children: advocating for treatment options in outpatient and field settings.

Miller BS, Spencer SP, Geffner ME, Gourgari E, Lahoti A, Kamboj MK, Stanley TL, Uli NK, Wicklow BA, Sarafoglou K.

J Investig Med. 2019 Feb 28. pii: jim-2019-000999. doi: 10.1136/jim-2019-000999. [Epub ahead of print]

PMID:
30819831
3.

Association of Gestational Diabetes and Type 2 Diabetes Exposure In Utero With the Development of Type 2 Diabetes in First Nations and Non-First Nations Offspring.

Wicklow BA, Sellers EAC, Sharma AK, Kroeker K, Nickel NC, Philips-Beck W, Shen GX.

JAMA Pediatr. 2018 Aug 1;172(8):724-731. doi: 10.1001/jamapediatrics.2018.1201.

4.

Maternal obesity, diabetes during pregnancy and epigenetic mechanisms that influence the developmental origins of cardiometabolic disease in the offspring.

Agarwal P, Morriseau TS, Kereliuk SM, Doucette CA, Wicklow BA, Dolinsky VW.

Crit Rev Clin Lab Sci. 2018 Mar;55(2):71-101. doi: 10.1080/10408363.2017.1422109. Epub 2018 Jan 8. Review.

PMID:
29308692
5.

Is the change in body mass index among children newly diagnosed with type 1 diabetes mellitus associated with obesity at transition from pediatric to adult care?

Manyanga T, Sellers EA, Wicklow BA, Doupe M, Fransoo R.

Pediatr Diabetes. 2016 Dec;17(8):599-607. doi: 10.1111/pedi.12344. Epub 2016 Jan 8.

PMID:
26748829
6.

The Metabolic Phenotype of Youth Onset Type 2 Diabetes: The Role of Pregestational Diabetes Exposure and the Hepatic Nuclear Factor 1Alpha G319S Polymorphism.

Charison J, Wicklow BA, Dean HJ, Sellers EA.

Can J Diabetes. 2016 Jun;40(3):210-5. doi: 10.1016/j.jcjd.2015.10.003. Epub 2016 Mar 3.

PMID:
27087001
7.

Cardiac mitochondrial energy metabolism in heart failure: Role of cardiolipin and sirtuins.

Dolinsky VW, Cole LK, Sparagna GC, Hatch GM.

Biochim Biophys Acta. 2016 Oct;1861(10):1544-54. doi: 10.1016/j.bbalip.2016.03.008. Epub 2016 Mar 10. Review.

PMID:
26972373
8.

Not as skinny as we used to think: Body mass index in children and adolescents at diagnosis of type 1 diabetes mellitus.

Manyanga T, Sellers EA, Wicklow BA, Doupe M, Fransoo R.

J Diabetes Complications. 2016 Mar;30(2):292-4. doi: 10.1016/j.jdiacomp.2015.11.022. Epub 2015 Dec 1.

PMID:
26718935
9.

Proposed trial: safety and efficacy of resveratrol for the treatment of non-alcoholic fatty liver disease (NAFLD) and associated insulin resistance in adolescents who are overweight or obese adolescents - rationale and protocol.

Wicklow B, Wittmeier K, T' Jong GW, McGavock J, Robert M, Duhamel T, Dolinsky VW.

Biochem Cell Biol. 2015 Oct;93(5):522-30. doi: 10.1139/bcb-2014-0136. Epub 2015 Jul 10.

PMID:
26305052
10.

Exploring the role of the HNF-1αG319S polymorphism in β cell failure and youth-onset type 2 diabetes: Lessons from MODY and Hnf-1α-deficient animal models.

Jonasson ME, Wicklow BA, Sellers EA, Dolinsky VW, Doucette CA.

Biochem Cell Biol. 2015 Oct;93(5):487-94. doi: 10.1139/bcb-2015-0021. Epub 2015 May 6. Review.

PMID:
26176428
11.

Pancreatic lipid content is not associated with beta cell dysfunction in youth-onset type 2 diabetes.

Wicklow BA, Griffith AT, Dumontet JN, Venugopal N, Ryner LN, McGavock JM.

Can J Diabetes. 2015 Oct;39(5):398-404. doi: 10.1016/j.jcjd.2015.04.001. Epub 2015 Jun 19.

PMID:
26099932
12.

Comparison of anthropometric measurements in children to predict metabolic syndrome in adolescence: analysis of prospective cohort data.

Wicklow BA, Becker A, Chateau D, Palmer K, Kozyrskij A, Sellers EA.

Int J Obes (Lond). 2015 Jul;39(7):1070-8. doi: 10.1038/ijo.2015.55. Epub 2015 Apr 14.

PMID:
25869598
13.

Resveratrol prevents pathological but not physiological cardiac hypertrophy.

Dolinsky VW, Soltys CL, Rogan KJ, Chan AY, Nagendran J, Wang S, Dyck JR.

J Mol Med (Berl). 2015 Apr;93(4):413-25. doi: 10.1007/s00109-014-1220-8. Epub 2014 Nov 15.

PMID:
25394677
14.

The Improving Renal Complications in Adolescents With Type 2 Diabetes Through the REsearch (iCARE) Cohort Study: rationale and Protocol.

Dart AB, Wicklow BA, Sellers EA, Dean HJ, Malik S, Walker J, Chateau D, Blydt-Hansen TD, McGavock JM; iCARE investigators.

Can J Diabetes. 2014 Oct;38(5):349-55. doi: 10.1016/j.jcjd.2014.07.224. Review.

PMID:
25284698
15.

Maternal health issues and cardio-metabolic outcomes in the offspring: a focus on Indigenous populations.

Wicklow BA, Sellers EA.

Best Pract Res Clin Obstet Gynaecol. 2015 Jan;29(1):43-53. doi: 10.1016/j.bpobgyn.2014.04.017. Epub 2014 Aug 20. Review.

PMID:
25238683
16.

Experimental studies of the molecular pathways regulated by exercise and resveratrol in heart, skeletal muscle and the vasculature.

Dolinsky VW, Dyck JR.

Molecules. 2014 Sep 18;19(9):14919-47. doi: 10.3390/molecules190914919. Review.

17.

Dietary determinants of hepatic steatosis and visceral adiposity in overweight and obese youth at risk of type 2 diabetes.

Mollard RC, Sénéchal M, MacIntosh AC, Hay J, Wicklow BA, Wittmeier KD, Sellers EA, Dean HJ, Ryner L, Berard L, McGavock JM.

Am J Clin Nutr. 2014 Apr;99(4):804-12. doi: 10.3945/ajcn.113.079277. Epub 2014 Feb 12.

PMID:
24522441
18.

Resveratrol prevents hypertension and cardiac hypertrophy in hypertensive rats and mice.

Dolinsky VW, Chakrabarti S, Pereira TJ, Oka T, Levasseur J, Beker D, Zordoky BN, Morton JS, Nagendran J, Lopaschuk GD, Davidge ST, Dyck JR.

Biochim Biophys Acta. 2013 Oct;1832(10):1723-33. doi: 10.1016/j.bbadis.2013.05.018. Epub 2013 May 22.

19.

Both aerobic exercise and resveratrol supplementation attenuate doxorubicin-induced cardiac injury in mice.

Dolinsky VW, Rogan KJ, Sung MM, Zordoky BN, Haykowsky MJ, Young ME, Jones LW, Dyck JR.

Am J Physiol Endocrinol Metab. 2013 Jul 15;305(2):E243-53. doi: 10.1152/ajpendo.00044.2013. Epub 2013 May 21.

20.

Success with lifestyle monotherapy in youth with new-onset type 2 diabetes.

Wittmeier KD, Wicklow BA, Sellers EA, Griffith AT, Dean HJ, McGavock JM.

Paediatr Child Health. 2012 Mar;17(3):129-32.

Supplemental Content

Loading ...
Support Center